Third International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer

February 24-27, 2010 • Fairmont Hotel • Washington, DC

Sponsored by the Duke University School of Medicine



Accreditation Statement
The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The Duke University School of Medicine designates this educational activity for a maximum of 24.75 AMA PRA Category 1 Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.  

Commercial Support Statement
This CME activity is supported by educational grants. A complete list of supporters will be published in the course syllabus.

Statement of Need
This Symposium will explore diagnosis, imaging techniques and treatment options for early stage, small volume prostate and kidney cancers.  Focal therapy is a relatively new method recognized as an organ-sparing, minimally invasive treatment alternative for prostate cancer, to traditional radical surgery and radiation therapy. The Symposium will present recent data concerning the pathologic and molecular characteristics of small prostate and kidney cancers, biopsy strategies to detect small tumor foci, imaging cancer within the prostate and kidney, patient selection criteria, and future directions in treatment.

Target Audience
This educational activity is designed for urologists, radiation oncologists, radiologists, medical oncologists, and uropathologists.

Learning Objectives
At the conclusion of this activity participants should be able to: 

• Identify the modalities suitable for focal therapy for prostate cancer
• Identify small prostate cancer foci through the use of functional and molecular imaging
• Apply appropriate patient selection criteria and thus identify suitable candidates for focal therapy
• Implement the appropriate techniques for diagnosing and treating patients with renal cancer

Faculty Disclosure
The Duke University School of Medicine adheres to ACCME Essential Areas, Standards, and Policies regarding industry support of continuing medical education.  Disclosure of the planning committee and faculty’s commercial relationships will be made known at the activity.  Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

Resolution of Conflicts of Interest
In accordance with the ACCME Standards for Commercial Support of CME, the Duke University School of Medicine will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Disclaimer
The information provided at this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Special Needs Statement
The Duke Comprehensive Cancer Center is committed to making its activities accessible to all individuals. If you are in need of an accommodation, please do not hesitate to call and/or submit a description of your needs in writing in order to receive service.